Provided by Tiger Trade Technology Pte. Ltd.

Global X Video Games & Esports ETF

27.34
+0.24000.89%
Post-market: 27.340.00000.00%19:30 EDT
Volume:19.48K
Turnover:531.38K
Market Cap:63.15M
PE:-0.04
High:27.43
Open:27.30
Low:27.11
Close:27.10
52wk High:34.09
52wk Low:23.46
Shares:2.31M
Float Shares:2.31M
Volume Ratio:1.38
T/O Rate:0.84%
Dividend:0.46
Dividend Rate:1.69%
EPS(TTM):-662.1600
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Unity weakness on Horizon hype ‘appears overdone,’ says Freedom Broker

TIPRANKS
·
Sep 25

Videogame Stocks Fall After Meta Announces AI Game Tool. Don't be Spooked Yet.

Dow Jones
·
Sep 25

Unity Software Inc Stock (U) Moved Down by 10.59% on Sep 24: Drivers Behind the Movement

TradingKey
·
Sep 25

Roblox put volume heavy and directionally bearish

TIPRANKS
·
Sep 25

Unity teams up with Meta for day-one Meta VR Glasses support

TIPRANKS
·
Sep 25

NetEase Files 2026 Interim Report with U.S. SEC

TIPRANKS
·
Sep 24

Take-Two participates in a conference call with StoneX

TIPRANKS
·
Sep 24

Hacked FBI Data Has Sensitive Information About Employees’ Intelligence Roles

Reuters
·
Sep 24

Unity Software call volume above normal and directionally bullish

TIPRANKS
·
Sep 24

US Companies Face Rise in Cyber Attacks

Reuters
·
Sep 23

Goldman Sachs Maintains Buy Rating on NetEase with HK$263 Price Target

Stock News
·
Sep 23

Indonesia Urges Roblox to Strengthen Child Safety Measures

Tempo
·
Sep 23

Take-Two Shareholders Approve Governance Changes and Director Slate

TIPRANKS
·
Sep 23

Take-Two Holds Annual Shareholder Meeting Via Webcast

Reuters
·
Sep 23

EA’s ‘Star Wars Zero Company’ surpasses 1M units sold, says Alinea Analytics

TIPRANKS
·
Sep 23

Turkey's Erdogan Urges UN Reform, Wider Recognition of Palestinian State

Reuters
·
Sep 23

Netease Declares Dividend of R$ 0.24 Per Unit for Brnetebdr006

Reuters
·
Sep 22

BNP Paribas Initiates Netease at Outperform With $180 Price Target

MT Newswires Live
·
Sep 22

Roblox (RBLX) Receives a Hold from TD Cowen

TIPRANKS
·
Sep 21

Tiziana Announces Last Patient Completes Last Visit in Phase 2a INFORM-MS Trial of Intranasal Foralumab

GlobeNewswire
·
Sep 21